|
Note 11 — Share-based compensation
The following table shows the total share-based compensation expense included in the unaudited consolidated statements of operations (in thousands):
|
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
|
March 31, |
|
|
|
2021 |
|
2020 |
|
|
Research and development |
|
$ |
2,375 |
|
$ |
978 |
|
|
General and administrative |
|
|
2,959 |
|
|
470 |
|
|
|
|
$ |
5,334 |
|
$ |
1,448 |
|
|
The following table shows information about share options and options which have a nominal exercise price (similar to restricted stock units (RSUs)) granted:
|
|
|
|
|
|
|
|
|
|
Three months ended |
|
|
March 31, |
|
|
2021 |
|
2020 |
|
Number of options over ordinary shares granted |
|
|
14,803,056 |
|
|
10,229,280 |
|
Weighted average fair value of ordinary shares options |
|
$ |
0.75 |
|
$ |
0.51 |
|
Number of additional options with a nominal exercise price granted |
|
|
12,663,792 |
|
|
6,060,696 |
|
Weighted average fair value of options with a nominal exercise price |
|
$ |
1.03 |
|
$ |
0.74 |
|
|